Table 1.
Demographic and baseline clinical characteristics of the study cohort. All data are shown as N (%).
| Variable | Overall | MIS-C labeled | Not MIS-C labeled |
|---|---|---|---|
| N | 1526 | 684 | 842 |
| Sex (male) | 840 (55) | 398 (58) | 442 (52) |
| Age (years) | |||
| 0 – <1 | 242 (16) | 38 (6) | 204 (24) |
| 1–5 | 332 (22) | 196 (29) | 136 (16) |
| 6–12 | 428 (28) | 277 (40) | 151 (18) |
| 13–21 | 521 (34) | 172 (25) | 349 (41) |
| Missing/unknown | 3 (0) | 1 (0) | 2 (0) |
| Race/Ethnicity | |||
| White, non-Hispanic | 278 (18) | 109 (16) | 169 (20) |
| Black, non-Hispanic | 408 (27) | 213 (31) | 195 (23) |
| Hispanic or Latino | 570 (37) | 226 (33) | 344 (41) |
| Other, non-Hispanic | 100 (7) | 39 (6) | 61 (7) |
| Unknown | 170 (11) | 97 (14) | 73 (9) |
| Insurance | |||
| Public | 1018 (67) | 417 (61) | 601 (71) |
| Self-pay | 56 (4) | 30 (4) | 26 (3) |
| Private | 354 (23) | 188 (27) | 166 (20) |
| Other or Unknown | 98 (6) | 49 (7) | 49 (6) |
| At least one underlying condition* | 737 (48) | 221 (32) | 516 (61) |
| Respiratory | 302 (20) | 90 (13) | 212 (25) |
| Cardiovascular | 102 (7) | 23 (3) | 79 (9) |
| Neurological/Neuromuscular | 171 (11) | 35 (5) | 136 (16) |
| Oncologic | 55 (4) | 10 (1) | 45 (5) |
| Immunosuppressed | 40 (3) | 4 (1) | 36 (4) |
| Rheumatologic/Autoimmune | 24 (2) | 7 (1) | 17 (2) |
| Hematologic | 87 (6) | 13 (2) | 74 (9) |
| Renal or Urologic | 64 (4) | 10 (1) | 54 (6) |
| Gastrointestinal/Hepatic | 155 (10) | 27 (4) | 128 (15) |
| Endocrine | 118 (8) | 18 (3) | 100 (12) |
| Genetic/Metabolic (excluding obesity) | 63 (4) | 12 (2) | 51 (6) |
| Trisomy 21 | 13 (1) | 2 (0) | 11 (1) |
⁎
Underlying conditions are not mutually exclusive.